ADEMEX

ADEquacy of Peritoneal Dialysis in Mexico. The largest interventional study ever conducted in peritoneal dialysis (PD), which examined the effects of increasing peritoneal small solute clearances on mortality rates among patients on continuous ambulatory peritoneal dialysis (CAPD).
Conclusion Pre-ADEMEX assumptions held that increasing small solute clearances would reduce morbidity and/or improve patient survival; it does not.

References in periodicals archive ?

Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: Ademex, A prospective randomized controlled trial.

EXPERIENCE OF PERITONEAL DIALYSIS IN RENAL FAILURE IN CHILDREN

Vonesh et al., "Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial," Journal of the American Society of Nephrology, vol.

Elevation of Platelet and Monocyte Activity Markers of Atherosclerosis in Haemodialysis Patients Compared to Peritoneal Dialysis Patients

However, the ADEMEX trial has demonstrated that no survival advantage was obtained with increases in peritoneal small-solute clearances within usual PD dosing regimens.

Influence of Peritoneal Transport Characteristics on Nutritional Status and Clinical Outcome in Chinese Diabetic Nephropathy Patients on Peritoneal Dialysis

Assessing creatinine clearance from Modification of Diet in Renal Disease Study equations in the ADEMEX Cohort: Limitations and potential applications.

Choice of GFR estimating equation influences dialysis initiation and mortality

Este rango de valores objetivo entre 1,2 y 1,4 resulta de trabajos como HEMO o Ademex, al concluir ambos que valores superiores no traen beneficio adicional significativo para el paciente, en terminos de mejora de la supervivencia.

Efecto de ajuste del flujo dializante (Qd) sobre la eficacia en hemodialisis a pacientes de bajo peso

Previously, he was global medical director of the Renal Division of Baxter Healthcare, and initiated and led the ADEMEX (ADEquacy of peritoneal dialysis in MEXico) study.

DaVita names John Moran VP Clinical Affairs - Home Therapies

I will examine the perceptions from the CANUSA (1996) study, HEMO trial (2002), ADEMEX study (2002) and Hong Kong study by Lo et al.

Diversity is the Key: People, ideas, information

CITE

Site: Follow: Share:

Open / Close